PT  - JOURNAL ARTICLE
AU  - Lee, Jeeyun
AU  - Cho, Byoung Chul
AU  - Lee, Jae Lyun
AU  - Lee, Jung-Yun
AU  - Campian, Jian L
AU  - Zhao, Yujie
AU  - Seetharam, Mahesh
AU  - Adjei, Alex A
AU  - Ma, Wen Wee
AU  - Chae, Dongwoo
AU  - Yun, Nari
AU  - Lee, Woosun
AU  - Lee, Wooyul
AU  - Park, Sosun
AU  - Seo, Bochan
AU  - Lee, Kyungwha
AU  - Park, Chong Woo
AU  - Jang, Myoung Ho
TI  - 729 A first-in-human, open-label, multicenter, phase 1/2a, dose escalation and expansion study of GI-102, a novel immunocytokine combining CD80-IL2v3, in patients with advanced or metastatic solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0729
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A824--A824
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A824.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A824.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.